Treatment with bexarotene, a compound that increases apolipoprotein-E, provides no cognitive benefit in mutant APP/PS1 mice (Q36958249)
Jump to navigation
Jump to search
scientific article published on 13 June 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Treatment with bexarotene, a compound that increases apolipoprotein-E, provides no cognitive benefit in mutant APP/PS1 mice |
scientific article published on 13 June 2013 |
Statements
1 reference
Treatment with bexarotene, a compound that increases apolipoprotein-E, provides no cognitive benefit in mutant APP/PS1 mice (English)
1 reference
Katherine D LaClair
1 reference
Kebreten F Manaye
1 reference
Dexter L Lee
1 reference
Joanne S Allard
1 reference
Alena V Savonenko
1 reference
Juan C Troncoso
1 reference
Philip C Wong
1 reference
13 June 2013
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference